Chembio Update on DPP(R) Ebola and DPP(R) Febrile Illness

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Chembio Update on DPP(R) Ebola and DPP(R) Febrile Illness Assays

MEDFORD, N.Y., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced its progress in the development of DPP ® Ebola and DPP ® Febrile Illness Assays.

On October 27, 2014 the Company announced an exclusive POC partnership with Integrated BioTherapeutics, Inc. (IBT), to combine Chembio's patented DPP ®  technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness.

Since announcing the partnership with IBT, the Company has made the following progress to develop DPP ® Ebola and DPP ® Febrile Illness Assays:

  • Developed DPP ® Ebola Assays in Chembio's Research & Development facilities.
  • Successfully tested DPP ® Ebola Assays in high containment (BSL4) laboratory, using wild type (real) Ebola virus, via IBT's partner in Canada.
  • Signed a Research Collaboration Agreement with the Centers for Disease Control and Prevention (CDC) to develop and validate DPP ® Ebola and DPP ® Febrile Illness Assays.
  • Successfully tested DPP ® Ebola Assays at CDC laboratory in Atlanta, GA.
  • Submitted DPP ® Ebola pre-qualification application to World Health Organization (WHO).
  • Contacted numerous organizations for Ebola funding, to accelerate our potential development, and potential manufacturing and supply of DPP ® Ebola and DPP ® Febrile Illness Assays, to include both Ebola and Malaria.

John Sperzel, Chembio's Chief Executive Officer, commented, "We are pleased with the rapid development of our DPP ® Ebola Assay. Our exclusive POC partnership with IBT has proven to be an important element of our strategy to quickly develop an Ebola test, as it provided access to well-characterized Ebola antibodies, BSL4 testing, and Ebola subject matter expertise. The results from initial laboratory testing, using real Ebola virus, look very promising pending field testing that will require additional approvals. Our goal is to provide DPP ® Ebola and DPP ® Febrile Illness Assays to the CDC and begin testing in West Africa during the first quarter of 2015, for which we are on track."

About Chembio Diagnostics

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets its DPP ® HIV 1/2 Assay and HIV 1/2 STAT-PAK ® Assay in the U.S. and internationally. The Company's SURE CHECK ® HIV 1/2 Assay is marketed exclusively in the U.S. as Clearview ® Complete. Outside the U.S., Chembio markets its SURE CHECK ® HIV 1/2 Assay through distributors.

Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP ® ) technology, which has significant advantages over lateral-flow technologies. This technology provides Chembio with a significant pipeline of business opportunities for the development and manufacture of new products.

Headquartered in Medford, NY, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U.S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13485. Chembio Diagnostic Systems, Inc. is a wholly-owned subsidiary of Chembio Diagnostics, Inc. For more information, please visit: www.chembio.com .

Forward-Looking Statements

Statements contained herein that are not historical facts may be forward-looking statements within the meaning of the Securities Act of 1933, as amended. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements, which are estimates only, reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to Chembio's ability to obtain additional financing and to obtain regulatory approvals in a timely manner, as well as the demand for Chembio's products. Chembio undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in Chembio's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact Chembio's success are more fully disclosed in Chembio's most recent public filings with the U.S. Securities and Exchange Commission.

Chembio Diagnostics Susan Norcott (631) 924-1135, ext. 125 Vida Strategic Partners (investor relations) Stephanie C. Diaz (415) 675-7401

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 173

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 0

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 43

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Broadridge Brings Boyman In to Sharpen Its Market Story

Updated Category News Views 44

Financial plumbing rarely gets applause, which is precisely why Broadridge needs somebody who can explain its value without turning the pitch into alphabet soup. Lauren Boyman arrives as chief marketing and communications officer on November 23, taking charge of global marketing, corporate communications, product positioning, digital strategy, lead generation and thought...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 44

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
UN Integrity Accelerator Targets Corporate Corruption

Updated Category News Views 84

Corruption rarely arrives wearing a villain costume; it shows up as a rushed payment, a friendly intermediary, or a contract nobody wants examined too closely. That is why the United Nations Global Compact's new Business Integrity Accelerator deserves a sober look. Launched November 18, 2026, the programme is not a magic shield, and nobody should sell it as one. But it...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 0

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Humanoid Robots Need Results Before 2035 Hype Peaks

Updated Category News Views 178

A robot climbing stairs is neat; a robot finishing Tuesday’s shift is the investment case. The latest humanoid robotics forecast puts the global market at $3.07 billion in 2026, up from $2.26 billion in 2025, and projects $47.49 billion by 2035. That is a 35.59% compound annual growth rate, the kind of number that makes investors sit up straight. It also demands a...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 0

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 26

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading

Top 5 Most Recently Viewed Articles

Charlotte's Web Moves Forward with AJA001 Autism Treatment Trial

Updated Category News Views 280

Charlotte's Web Progresses to Phase 2 in Autism Treatment Charlotte's Web Holdings, Inc. (TSX: CWEB) has announced an important step in the development of its botanical drug known as AJA001, aimed at treating symptoms associated with autism spectrum disorder (ASD). The U.S. Food and Drug Administration (FDA) has officially issued a green light for Charlotte's Web and its...

Continue Reading
Uptown Cheapskate and Kid to Kid Celebrate Monumental Growth

Updated Category News Views 257

Uptown Cheapskate and Kid to Kid Celebrate Monumental Growth Uptown Cheapskate and Kid to Kid have reached an amazing milestone, surpassing $300 million in system-wide sales during a recent year, showcasing a remarkable growth of over 20% compared to the previous year. This achievement is a testament to the increasing consumer demand for thrift shopping and the unique...

Continue Reading
Exploring the Thriving Landscape of Smart Wearables Market Trends

Updated Category News Views 146

Overview of the Smart Wearables Market Growth The Smart Wearables market is on an exciting upward trajectory, expected to surge from its valuation of USD 77.95 billion to an impressive USD 319.42 billion by 2032. With a robust compound annual growth rate (CAGR) of 19.34%, the sector reflects significant consumer interest and technological advancements. This remarkable...

Continue Reading
Exciting Partnership: Bass Pro Shops and the SMX League Unite

Updated Category News Views 239

Bass Pro Shops Teams Up With The SMX League Bass Pro Shops is set to become the official partner across the entire SMX racing calendar. One of the most thrilling events to look forward to is the Monster Energy SMX World Championship Final, which is scheduled to take place at Thunder Ridge, creating an exciting experience for fans. Venue Selection for The Championship...

Continue Reading
ADI Foundation Launches Innovative ADI Chain Mainnet and Token

Updated Category News Views 172

Exciting Developments from the ADI Foundation The ADI Foundation has recently launched the mainnet of ADI Chain along with its native ADI utility token. This significant step establishes a specialized Layer-2 blockchain aimed at enhancing operations for governments, regulated entities, and various real-world applications. By creating a tailored blockchain environment, the...

Continue Reading